SAIL Fusion develops sacroiliac-joint fusion technology, applying AO Foundation principles to its proprietary BowTie SI Fusion System. The company’s posterior-inferior approach is designed around minimal tissue disruption, thorough joint preparation and rigid fixation, and its system is offered exclusively to orthopedic and neurological spine surgeons. SAIL Fusion bases its technologies on published scientific evidence and is validating BowTie through biomechanical and clinical research, including a prospective patient study initiated in 2023.